These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25700649)

  • 1. [HDL and atherosclerotic cardiovascular diseases].
    Windler E; Nitschmann S
    Internist (Berl); 2015 Apr; 56(4):446-50. PubMed ID: 25700649
    [No Abstract]   [Full Text] [Related]  

  • 2. HDL cholesterol efflux capacity and incident cardiovascular events.
    Rohatgi A; Khera A; Berry JD; Givens EG; Ayers CR; Wedin KE; Neeland IJ; Yuhanna IS; Rader DR; de Lemos JA; Shaul PW
    N Engl J Med; 2014 Dec; 371(25):2383-93. PubMed ID: 25404125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
    Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
    Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The not-so-simple HDL story: A new era for quantifying HDL and cardiovascular risk?
    Heinecke JW
    Nat Med; 2012 Sep; 18(9):1346-7. PubMed ID: 22961165
    [No Abstract]   [Full Text] [Related]  

  • 5. The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis?
    Rader DJ; Tall AR
    Nat Med; 2012 Sep; 18(9):1344-6. PubMed ID: 22961164
    [No Abstract]   [Full Text] [Related]  

  • 6. Re-examining the high-density lipoprotein hypothesis.
    Tan K
    J Diabetes Investig; 2016 Jul; 7(4):445-7. PubMed ID: 27181708
    [No Abstract]   [Full Text] [Related]  

  • 7. High-density lipoproteins, reverse cholesterol transport and atherosclerosis--recent developments.
    Berger GM
    S Afr Med J; 1984 Mar; 65(13):503-6. PubMed ID: 6710253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL modification: recent developments and their relevance to atherosclerotic cardiovascular disease.
    Wilkins JT; Seckler HS
    Curr Opin Lipidol; 2019 Feb; 30(1):24-29. PubMed ID: 30531230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
    Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
    Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of three consecutive meals on the physicochemical properties of HDL and LDL in individuals with the metabolic syndrome and patients with type 2 diabetes.
    Scheffer PG; Tushuizen ME; Vermue HP; Schindhelm RK; Rustemeijer C; Diamant M
    Eur J Clin Nutr; 2011 Nov; 65(11):1242-9. PubMed ID: 21712838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae.
    Soran H; Schofield JD; Liu Y; Durrington PN
    Curr Opin Lipidol; 2015 Aug; 26(4):247-56. PubMed ID: 26103614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cigarette smoking on HDL quantity and function: implications for atherosclerosis.
    He BM; Zhao SP; Peng ZY
    J Cell Biochem; 2013 Nov; 114(11):2431-6. PubMed ID: 23852759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein profile in patients who survive a stroke.
    Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
    Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDL and atherothrombotic vascular disease.
    Annema W; von Eckardstein A; Kovanen PT
    Handb Exp Pharmacol; 2015; 224():369-403. PubMed ID: 25522995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoproteins and coronary heart disease.
    Krauss RM
    Postgrad Med; 1989 Apr; Spec No():54-8; discussion 89-90. PubMed ID: 2726627
    [No Abstract]   [Full Text] [Related]  

  • 16. The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis.
    Liao KP; Playford MP; Frits M; Coblyn JS; Iannaccone C; Weinblatt ME; Shadick NS; Mehta NN
    J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of gender and serum estradiol levels on HDL-mediated reverse cholesterol transport.
    Badeau RM; Metso J; Kovanen PT; Lee-Rueckert M; Tikkanen MJ; Jauhiainen M
    Eur J Clin Invest; 2013 Apr; 43(4):317-23. PubMed ID: 23397902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective study of the relationship between biomarkers of atherosclerosis and erectile dysfunction in 988 men.
    Eaton CB; Liu YL; Mittleman MA; Miner M; Glasser DB; Rimm EB
    Int J Impot Res; 2007; 19(2):218-25. PubMed ID: 16915303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in cholesterol transport by lipoproteins in patients with renal insufficiency].
    Pérez A; Alegre B; Panadero J; Martín L; Breto M; Cruz JM
    Rev Clin Esp; 1983 Jan; 168(1):13-6. PubMed ID: 6844674
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination methods and clinical significance of HDL-cholesterol (author's transl)].
    Fukui I
    Rinsho Byori; 1981 Nov; 29(11):1071-8. PubMed ID: 7334659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.